Viewing Study NCT03217903


Ignite Creation Date: 2025-12-24 @ 7:41 PM
Ignite Modification Date: 2025-12-30 @ 4:44 PM
Study NCT ID: NCT03217903
Status: UNKNOWN
Last Update Posted: 2019-08-06
First Post: 2017-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE)
Sponsor: Central Hospital, Nancy, France
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module